Century Therapeutics (IPSC) Shares Outstanding (Diluted) (2020 - 2026)
Powered by 
Analysis
Century Therapeutics (IPSC) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Century Therapeutics | 439.34 Mn | 179.26 Mn | - | 205.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 205.78 Mn |
| Mar 31, 2026 | 193.47 Mn |
| Dec 31, 2025 | 86.56 Mn |
| Sep 30, 2025 | 86.46 Mn |
| Jun 30, 2025 | 86.24 Mn |
| Mar 31, 2025 | 86.10 Mn |
| Dec 31, 2024 | 78.65 Mn |
| Sep 30, 2024 | 84.70 Mn |
| Jun 30, 2024 | 82.09 Mn |
| Mar 31, 2024 | 62.30 Mn |
| Dec 31, 2023 | 57.76 Mn |
| Sep 30, 2023 | 59.45 Mn |
| Jun 30, 2023 | 59.25 Mn |
| Mar 31, 2023 | 58.61 Mn |
| Dec 31, 2022 | 57.76 Mn |
| Sep 30, 2022 | 57.97 Mn |
| Jun 30, 2022 | 57.69 Mn |
| Mar 31, 2022 | 57.05 Mn |
| Dec 31, 2021 | 32.39 Mn |
| Sep 30, 2021 | 54.47 Mn |